N-Myristoyltransferase as a Glycine and Lysine Myristoyltransferase in Cancer, Immunity, and Infections. Review uri icon

Overview

abstract

  • Protein myristoylation, the addition of a 14-carbon saturated acyl group, is an abundant modification implicated in biological events as diverse as development, immunity, oncogenesis, and infections. N-Myristoyltransferase (NMT) is the enzyme that catalyzes this modification. Many elegant studies have established the rules guiding the catalysis including substrate amino acid sequence requirements with the indispensable N-terminal glycine, and a co-translational mode of action. Recent advances in technology such as the development of fatty acid analogs, small molecule inhibitors, and new proteomic strategies, allowed a deeper insight into the NMT activity and function. Here we focus on discussing recent work demonstrating that NMT is also a lysine myristoyltransferase, the enzyme's regulation by a previously unnoticed solvent channel, and the mechanism of NMT regulation by protein-protein interactions. We also summarize recent findings on NMT's role in cancer, immunity, and infections and the advances in pharmacological targeting of myristoylation. Our analyses highlight opportunities for further understanding and discoveries.

publication date

  • June 10, 2020

Research

keywords

  • Acyltransferases
  • Communicable Diseases
  • Immunity, Innate
  • Neoplasms
  • Proteins

Identity

PubMed Central ID

  • PMC7841852

Scopus Document Identifier

  • 85088272296

Digital Object Identifier (DOI)

  • 10.1021/acschembio.0c00314

PubMed ID

  • 32453941

Additional Document Info

volume

  • 15

issue

  • 7